]>
IRCT20230715058781N1 IRCT 2023-07-17 Ghoum University of Medical Sciences Investigating the effect of saffron on the consciousness of stroke patients Investigating the effectiveness of saffron medicine on the prognosis of ischemic CVA patients with NIHSS less than 15 2023-09-23 anticipated 74 Complete https://irct.ir/trial/71310 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients are divided into two groups using the randomized balanced block method with block sizes of 4 and 6. The random sequence is generated by an epidemiologist by running an online program on the website (https://www.sealedenvelope.com). Allocation concealment is also guaranteed due to the use of special codes generated by the website. 3 cerebrovascular accident. Intervention 1: Intervention group: Including 37 patients who will receive 30 mg of saffron capsules from Duralife -Faran Chemi Pharmaceutical Company (15 mg twice a day) for 30 days orally in addition to the usual treatment(including anti platelet, statin, blood sugar and blood pressure control) in the intensive care unit. Intervention 2: Control group: 37 patients who will receive only routine care(including anti platelet, statin, blood sugar, and blood pressure control. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no further information
public Somayeh Mehrpour
Beheshti Hospital
QOM Iran (Islamic Republic of) 3719964797 +98 25 3612 2000 somayeh.mehrpour@gmail.com Ghoum University of Medical Sciences scientific Somayeh Mehrpour
Beheshti Hospital
QOM Iran (Islamic Republic of) 3719964797 +98 25 3612 2000 somayeh.mehrpour@gmail.com Ghoum University of Medical Sciences Iran (Islamic Republic of) Patients with ischemic stroke 18 years no limit Both Coagulation disorders G46.4 Cerebellar stroke syndrome Treatment - Drugs Treatment - Drugs Intervention group: Including 37 patients who will receive 30 mg of saffron capsules from Duralife -Faran Chemi Pharmaceutical Company (15 mg twice a day) for 30 days orally in addition to the usual treatment(including anti platelet, statin, blood sugar and blood pressure control) in the intensive care unit. Control group: 37 patients who will receive only routine care(including anti platelet, statin, blood sugar, and blood pressure control. Level of consciousness. Timepoint: arrival; hospitalization time; while receiving medication. Method of measurement: Glasgow coma scale. Length of hospitalization. Timepoint: The time of the patient's discharge from the hospital. Method of measurement: National Institutes Of Health Stroke Scale. Ghoum University of Medical Sciences Approved 2023-05-15 Research Ethics Committees of Qom University of Medical Sciences No. 83, Shahid Lotfi Niaser Ave, Safashehr Blvd Qom Ghoum Iran (Islamic Republic of)